Chen Fei, Rezavi Reza, Wang Cha-Chi, Harrison Lawrence E
Division of Surgical Oncology, UMDNJ - New Jersey Medical School, Newark, NJ 07103, USA.
Oncology. 2007;73(1-2):98-103. doi: 10.1159/000120997. Epub 2008 Mar 13.
The purpose of this study was to investigate whether proteasome inhibition acts as a thermal sensitizing agent to induce tumor cell death in a colon cancer cell line.
HT-29 colon cancer cells were exposed to hyperthermia (43 degrees C) in the presence of proteasome inhibition for 1 h. Viable cell mass and apoptosis were measured by MTT and annexin V staining, respectively. Protein levels were determined by Western blot analysis.
A significant synergistic effect on cell viability with proteasome inhibition was noted under hyperthermic conditions compared to hyperthermia alone (p < 0.05). Increases in phosphorylated ERK and decreases in HSP27 levels were observed in the cells exposed to proteasome inhibition at 43 degrees C. Pretreatment with an inhibitor of ERK yielded an additional increase in apoptosis when used in combination with proteasome inhibition and hyperthermia. Decreased expression of HSP27 by siRNA also resulted in increased thermally induced apoptotic cell death.
Thermal sensitization through proteasome inhibition may represent a novel approach to increase the efficacy of hyperthermia as an anticancer modality.
本研究的目的是调查蛋白酶体抑制是否作为一种热敏化剂在结肠癌细胞系中诱导肿瘤细胞死亡。
将HT-29结肠癌细胞在蛋白酶体抑制存在的情况下暴露于热疗(43摄氏度)1小时。分别通过MTT和膜联蛋白V染色测量活细胞数量和细胞凋亡情况。通过蛋白质印迹分析确定蛋白质水平。
与单独热疗相比,在热疗条件下观察到蛋白酶体抑制对细胞活力有显著的协同作用(p < 0.05)。在43摄氏度下暴露于蛋白酶体抑制的细胞中观察到磷酸化ERK增加和HSP27水平降低。当与蛋白酶体抑制和热疗联合使用时,用ERK抑制剂预处理会使细胞凋亡进一步增加。通过siRNA降低HSP27的表达也导致热诱导的凋亡细胞死亡增加。
通过蛋白酶体抑制实现的热敏化可能代表一种提高热疗作为抗癌方式疗效的新方法。